News: Dexa Group

Dexa Medica continues collaborating with diverse stakeholders to play an active role in the program to reduce stunting to 14% by 2024. Dexa Medica collaborated with the Indonesian National Army (TNI AD) and the Family Coordinating Agency National Planning (BKKBN) on this occasion to launch the e-Stuntad and e-Posyandu apps…

Dexa Medica participated in the Annual Scientific Meeting (PIT) of the Ikatan Apoteker Indonesia (IAI) in Solo City, Central Java, on August 24 -26, 2023, as a form of collaboration in supporting advancement and facing challenges in the pharmaceutical and health fields in accordance with the Dexa Medica's core purpose,…

In the 2024 Rancangan Anggaran Belanja dan Pendapatan Negara (RAPBN), President Joko Widodo allotted IDR 186.4 trillion, or 5.6 percent, towards the healthcare system. One of the primary goals is to reduce the prevalence of stunting in Indonesia by 14 percent by 2024. In this context, Hasto Wardoyo, the Head…

Dexa Group's Dexa Award Science Scholarship program won an award in the healthcare and consumer category at the B-Universe CSR Awards. The award organized by B-Universe has the theme "Maximizing Shared Value Through Sustainable CSR Initiatives". The realization of this CSR Awards award was initiated from the message that President…

The 2022 Indonesian Nutritional Status Survey (SSGI) shows that the national prevalence of stunting has decreased to by 2.8% to 21.6% compared to the previous year. Dexa Group collaborates with the National Population and Family Planning Board (BKKBN), the Indonesian National Police (Polri), and the Regional Government (Pemda) of Wonosobo…

Dexa Group is committed to supporting government programs to increase the use of domestic pharmaceutical products to achieve health resilience and independence. For this reason, the Ministry of Health presented three awards to Dexa Group at the National Forum for Down Streaming and Increasing the Use of Domestic Pharmaceutical Products…

Digital transformation in various sectors, including health services, is experiencing rapid changes, thus becoming an opportunity to create more advanced quality health services. This was conveyed by the Head of the Indonesian Army Health Center, Mayjen TNI, Dr. Purwo Setyanto, at Technical Guidance for Hospital CEOs of the Indonesian Army…

The President of the Republic of Indonesia (RI) Mr. Joko Widodo appreciated and encouraged the use of Indonesia Indigenous Modern Medicine (OMAI) in the National Health Insurance (JKN). This was conveyed during a visit to the Dexa Group booth with the theme OMAI Fitofarmaka at the Business Matching Exhibition for…

The Indonesian Pharmaceutical Companies Association (GP Farmasi) held an interactive dialogue entitled "Safe Medicinal Syrups for Children". It was revealed that the requirement for safe syrup preparations is in accordance with the provisions of the Food and Drug Administration (BPOM). "BPOM in conducting evaluations, in issuing permits, many standards are…

Dexa Group Wins Public Relations Indonesia Awards 2023 After going through a gradual judging process and presenting proposals, Dexa Group's Corporate Communications is considered to have a significant and positive impact on Public Relations (PR) performance throughout 2022. For this achievement, Dexa Group has won the highest award at the…